David A. Sinclair, Ph.D. is an entrepreneur and world leader in aging research. He is a tenured Professor of Genetics at Harvard Medical School, co-Director of the Paul F. Glenn Center for the Biological Mechanisms of Aging, Professor and Head of the Aging Labs at UNSW, Sydney, and an honorary Professor at the University of Sydney. He is best known for his work on genes and small molecules that delay aging, including the Sirtuin genes, resveratrol and NAD precursors. He has published over 160 scientific papers, is a co-inventor on over 50 patents, and has co-founded 12 biotechnology companies in the areas of aging, vaccines, diabetes, fertility, cancer, and biodefense. He serves as co-chief editor of the scientific journal Aging, works with national defense agencies and with NASA. He has received 35 honors including being one of Australia's leading scientists under 45, the CSL prize, an Advance Global Australian Award, an ASMR Medal, the NIH Director’s Pioneer award, TIME magazine’s list of the “100 most influential people in the world” and a Member of the Order of Australia in 2018.